Q3 2018 Holdings
Filed 2018-11-14 | 25 holdings | $538.4M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2019-08-22) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $332.0M | 10,825,919 | 61.7% |
| Biogen Inc(BIIB) | Common | 09062X103 | $104.1M | 294,564 | 19.3% |
| Agios Pharmaceuticals Inc(AGIO) | Common | 00847X104 | $101.6M | 1,317,459 | 18.9% |
| Theravance Biopharma Inc(TBPH) | Common | G8807B106 | $382.1K | 11,694,879 | 0.1% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $156.0K | 11,924,614 | 0.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $112.9K | 2,659,676 | 0.0% |
| Evofem Biosciences Inc(NEOTEUR) | Common | 30048L104 | $38.9K | 9,593,197 | 0.0% |
| Nucana PLC | SPON ADR | 67022C106 | $14.3K | 572,000 | 0.0% |
| Nightstar Therapeutics PLC | ADR | 65413A101 | $13.9K | 682,109 | 0.0% |